Mayo Clinic, Jacksonville Ponte Vedra Beach, Florida
We will review evidence supporting dose optimization in the management of patients with IBD. Participants to be able to recognize when a patient with IBD has had inadequate response to therapy, when to consider dose intensification and when to consider transition to new mechanism of action or surgery.
Learning Objectives:
Identify patients who are primary non-responders to IBD therapy
Recognize which IBD patients might benefit from dose optimization strategies
Understand the evidence supporting dose optimization with various IBD therapies